Indium (In-111) Chloride Curium

Indium-111, the active ingredient in Indium (In-111) Chloride Curium, is a radiopharmaceutical presented as a solution for injection for intravenous use. It is employed to image tumors, sites of inflammation, infection and for leukocyte labeling in scintigraphy.

GNH USA supplies Indium (In-111) Chloride Curium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, transplant centres and clinics worldwide.

Indium-111 chloride is used in nuclear medicine to visualize abnormal cellular activity in oncologic and inflammatory conditions.

Tumor imaging: provides high‑resolution images of malignant lesions for staging and treatment planning. Inflammation detection: highlights areas of active inflammation for diagnostic clarification. Infection localization: identifies focal infections to guide antimicrobial therapy. Leukocyte labeling for scintigraphy: labels white blood cells to locate sites of infection or inflammation.

Adverse reactions are generally mild but can occur after intravenous administration.

Common Side Effects: - Injection site pain or erythema - Nausea or mild vomiting - Transient headache - Flushing or warmth sensation - Metallic taste in the mouth - Temporary mild hypotension

Serious or Rare Side Effects: - Anaphylactic or severe allergic reaction - Radiation‑induced skin injury at the injection site - Severe hypotension or cardiovascular collapse - Arrhythmias related to radiation exposure - Bone marrow suppression with high cumulative doses - Organ toxicity in patients with impaired clearance

Use of Indium-111 chloride requires careful consideration of patient safety and handling. - Pregnancy: safety unknown; avoid unless diagnostic benefit outweighs risk. - Breastfeeding: unknown; consider discontinuing breastfeeding during and after administration. - Renal impairment: monitor renal function as excretion may be reduced. - Concurrent radiopharmaceuticals: avoid overlapping scans to prevent excess radiation dose. - Radiation safety: follow ALARA principles for staff and patient protection. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Indium-111 chloride may interact with other agents that affect radiation exposure or biodistribution.

Major Interactions (Avoid): - Other radiopharmaceuticals: cumulative radiation dose may exceed safety limits. - Myelosuppressive chemotherapy: increased risk of hematologic toxicity.

Moderate Interactions (Monitor Closely): - Iodinated contrast agents used in CT: may alter image interpretation. - Drugs altering plasma protein binding: could change tracer distribution. - Antihistamines: may mask early signs of an allergic reaction. - Beta‑blockers: may affect cardiovascular response to the tracer.